Knee Replacement News and Research

RSS

20% of patients demonstrate decrease in body weight, BMI after knee or hip replacement

A Mount Sinai School of Medicine study has found that patients often exhibit a significant decrease in weight and body mass index (BMI) after undergoing knee or hip replacement surgery (arthroplasty). The study is the first of its type to correct for the annual increase in BMI typically found in North Americans between the ages of 29 to 73 years. The study was recently published in Orthopedics.

27 Jul 2010

Britain plans to decentralize NHS, tranfer budget to general practitioners

British officials are proposing a plan to decentralize the National Health Service, news outlets report.

27 Jul 2010

Study analyses anesthetic effects on surgical site infections

A study appearing in the August 2010 issue of Anesthesiology found that patients receiving a total hip or knee replacement in Taiwan had a higher incidence of surgical site infections (SSIs) when general anesthesia was administered for the operation than when the same procedures were performed under epidural/spinal (regional) anesthesia.

27 Jul 2010

Columbia Asia opens new 82-bed medical facility in Nusajaya, Malaysia

Columbia Asia, a fast-growing hospital company with Pacific Northwest roots, is now part of a major new development in Nusajaya, Malaysia - a mere 10-minute drive from the bustling country of Singapore.

22 Jul 2010

Lifestyle changes can prevent arthritis, knee replacement

Taking a few small steps toward protecting your knees when you are younger might help you avoid debilitating problems when you get older.

21 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

Hip and knee specialist indicates five primary reasons why knee implant fails

While most knee replacements will function well for years, patients should be aware of the signs of failure—including increased pain or decreased function—that may require a corrective procedure known as revision total knee replacement, if necessary.

12 Jul 2010

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.

9 Jul 2010

Phase II trial results of TB-402 presented at International Congress on Thrombosis

BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

9 Jul 2010

Medical school association suggests clinical conflict-of-interest policies

The Association of American Medical Colleges has asked academic medical institutions to adopt conflict-of-interest policies for clinical care similar to those they apply to medical research, Modern Healthcare reports.

2 Jul 2010

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Three new oral blood-thinning drugs nearing approval by the Food and Drug Administration are more convenient than the standard drug Coumadin® because they do not require monthly visits to adjust doses.

2 Jun 2010

Exactech acquires Brighton Partners

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has acquired Brighton Partners, Inc., the sole source supplier of the direct compression molded polyethylene bearings used exclusively in Exactech's flagship product, the Optetrak® knee replacement system.

25 May 2010

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

6 May 2010

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.

6 May 2010

Additional pivotal Phase 3 trial data for MoxDuo IR released

QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.

5 May 2010

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Throughout the years orthopedic surgeons have learned that one size does not fit all when it comes to joint replacements. Because of advancements in technology, surgeons can now customize artificial knee implants and prevent future revision surgeries.

4 May 2010

Bristol-Myers Squibb reports 11% increase in first-quarter 2010 revenue

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the first quarter of 2010.

30 Apr 2010

$Ageing population prone to bone fractures drives South African joint replacement market$

Ageing population prone to bone fractures drives South African joint replacement market

The joint replacement market in South Africa is set to experience continued growth in the medium to long term, driven by an ageing population that is prone to cartilage degeneration and bone fractures. The introduction of innovative products with enhanced durability and longevity as well as safer operation techniques is further boosting growth in this market.

29 Apr 2010

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

ConforMIS, Inc. announced today that the iUni® G2 has received CE Mark certification, providing regulatory approval for ConforMIS to begin the sale of this products throughout the European Union. The iUni G2 is the next generation of ConforMIS' revolutionary patient-specific knee replacement system, and remains the only patient-specific unicompartmental knee resurfacing implant on the market.

15 Apr 2010

Computer-Assisted Robotic Total Knee Replacements better than conventional techniques

A study of 1,000 consecutive Computer-Assisted Robotic Total Knee Replacements performed over a five year period at Mercy Medical Center in Rockville Centre, NY demonstrates that the computer-assisted procedures result in far better leg alignment, much less likelihood of complicating infection, and a far lower early failure rate than surgeries performed using conventional techniques.

12 Apr 2010

Knee Replacement News and Research

20% of patients demonstrate decrease in body weight, BMI after knee or hip replacement

Britain plans to decentralize NHS, tranfer budget to general practitioners

Study analyses anesthetic effects on surgical site infections

Columbia Asia opens new 82-bed medical facility in Nusajaya, Malaysia

Lifestyle changes can prevent arthritis, knee replacement

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

Hip and knee specialist indicates five primary reasons why knee implant fails

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Medical school association suggests clinical conflict-of-interest policies

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Exactech acquires Brighton Partners

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

Additional pivotal Phase 3 trial data for MoxDuo IR released

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Bristol-Myers Squibb reports 11% increase in first-quarter 2010 revenue

Ageing population prone to bone fractures drives South African joint replacement market

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

Computer-Assisted Robotic Total Knee Replacements better than conventional techniques

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News